Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
Visualitza/
Impacte
Scholar |
Altres documents de l'autoria: Müller, Patrick; Meta, Mergim; Meidner, Jan Laurenz; Schwickert, Marvin; Meyr, Jessica; Schwickert, Dr. Kevin; Kersten, Christian; Zimmer, Collin; Hammerschmidt, Stefan Josef; Frey, Ariane; Lahu, Albin; de la hoz rodriguez, Sergio; Agost Beltrán, Laura; Rodríguez, Santiago; Diemer, Kira; Neumann, Wilhelm; González, Florenci; Engels, Bernd; Schirmeister, Tanja
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7053
comunitat-uji-handle3:10234/8639
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity StudyAutoria
Data de publicació
2023-04-13Editor
MDPIISSN
1661-6596; 1422-0067Cita bibliogràfica
Müller, Patrick, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, and et al. 2023. "Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study" International Journal of Molecular Sciences 24, no. 8: 7226. https://doi.org/10.3390/ijms24087226Tipus de document
info:eu-repo/semantics/articleVersió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
: Covalent peptidomimetic protease inhibitors have gained a lot of attention in drug development in recent years. They are designed to covalently bind the catalytically active amino acids
through electrophilic groups ... [+]
: Covalent peptidomimetic protease inhibitors have gained a lot of attention in drug development in recent years. They are designed to covalently bind the catalytically active amino acids
through electrophilic groups called warheads. Covalent inhibition has an advantage in terms of
pharmacodynamic properties but can also bear toxicity risks due to non-selective off-target protein
binding. Therefore, the right combination of a reactive warhead with a well-suited peptidomimetic
sequence is of great importance. Herein, the selectivities of well-known warheads combined with
peptidomimetic sequences suited for five different proteases were investigated, highlighting the
impact of both structure parts (warhead and peptidomimetic sequence) for affinity and selectivity.
Molecular docking gave insights into the predicted binding modes of the inhibitors inside the binding
pockets of the different enzymes. Moreover, the warheads were investigated by NMR and LC-MS
reactivity assays against serine/threonine and cysteine nucleophile models, as well as by quantum
mechanics simulations. [-]
Publicat a
Int. J. Mol. Sci. 2023, 24, 7226. https://doi.org/10.3390/ijms24087226Entitat finançadora
Deutsche Forschungsgemeinschaft (DFG) | Generalitat Valenciana | Universitat Jaume I | Ministerio de Ciencia, Innovación y Universidades
Codi del projecte o subvenció
project Q5 | CIPROM/2021/079 | UJI-B2021-71 | FPU19/04913
Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- QUIO_Articles [694]
Except where otherwise noted, this item's license is described as © 2023 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).